NON-FINAL ACTION - MAILED
final action
on 20 Dec 2024
Last Applicant/ Owned by
700 Dexter Ave N, Suite 1550
Seattle
WA
98109
Serial Number
98417497 filed on 22nd Feb 2024
Registration Number
N/A
Correspondent Address
Michael A. Geller
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SHAPETX
Provision of gene therapy services for medical treatment purposes Biomanufacturing for others, namely, manufacturing of pharmaceutical preparations for the treatment of genetic diseases and disorders using cells in the manufacturing process; biotechnical manufacturing for others, namely, manufacturing of pharmaceutical preparations for the treatment of genetic diseases and disorders
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Provision of gene therapy services for medical treatment purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Biomanufacturing for others, namely, manufacturing of pharmaceutical preparations for the treatment of genetic diseases and disorders using cells in the manufacturing process; biotechnical manufacturing for others, namely, manufacturing of pharmaceutical preparations for the treatment of genetic diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98417497
Mark Type
No Service Mark
Attorney Docket Number
No 421688.4
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Dec 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 20th Dec 2024 | NON-FINAL ACTION E-MAILED |
| 20th Dec 2024 | NON-FINAL ACTION WRITTEN |
| 22nd Oct 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 22nd Oct 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 22nd Oct 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 12th Sep 2024 | ASSIGNED TO EXAMINER |
| 12th Sep 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 12th Sep 2024 | NON-FINAL ACTION E-MAILED |
| 12th Sep 2024 | NON-FINAL ACTION WRITTEN |